Related Experiment Videos
[Intravesical chemotherapy for superficial bladder tumors]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|August 1, 1984
Summary
Intravesical chemotherapy effectively treats superficial bladder tumors. Adriamycin instillation showed 68% effectiveness with manageable side effects, though further study is needed for recurrence prevention.
Area of Science:
- Oncology
- Urology
Context:
- Superficial bladder tumors require effective treatment options.
- Intravesical chemotherapy is a promising approach for managing these tumors.
Purpose:
- To evaluate the effectiveness and side effects of adriamycin for intravesical chemotherapy in treating superficial bladder tumors.
- To explore the potential of intravesical chemotherapy in preventing tumor recurrence.
Summary:
- Adriamycin was selected for intravesical instillation due to its suitability.
- A regimen of six to nine adriamycin instillations (50 mg in 30 ml normal saline) demonstrated 68% effectiveness.
- Side effects were observed in 23% of patients, indicating a manageable safety profile.
Impact:
- Adriamycin offers a viable chemotherapeutic option for superficial bladder cancer.
- Further research is warranted to optimize intravesical chemotherapy protocols and assess long-term outcomes, particularly for recurrence prevention.